BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Cardiol. Jul 26, 2026; 18(7): 121228
Published online Jul 26, 2026. doi: 10.4330/wjc.121228
Table 1 Baseline demographic, clinical, and echocardiographic characteristics of the study cohort (n = 28)
Variable
Total (n = 28)
Survivors (n = 24)
Non-survivors (n = 4)
P value
Age (years)73.82 ± 12.1474.12 ± 11.6872.00 ± 16.570.819
Male sex, %61.964.750.00.618
Smoking, %21.420.825.01.000
Hypertension, %100.0100.0100.01.000
Dyslipidemia, %96.4100.075.00.143
Obesity, %29.630.425.01.000
Diabetes mellitus, %53.650.075.00.600
Valvular heart disease, %71.475.050.00.555
Systolic BP (mmHg)173.39 ± 38.52172.58 ± 39.94178.25 ± 33.050.772
Diastolic BP (mmHg)99.39 ± 21.2399.75 ± 22.5997.25 ± 11.700.746
Heart rate (bpm)105.61 ± 23.04105.75 ± 24.69104.75 ± 10.240.892
NT-proBNP (pg/mL)10513.96 ± 10381.239955.83 ± 10293.2713862.75 ± 11840.240.569
TAPSE (mm)22.61 ± 8.2023.29 ± 8.6118.50 ± 3.320.072
LVOT VTI (cm)16.20 ± 4.5216.03 ± 4.7217.23 ± 3.340.561
RV-RA gradient (mmHg)28.93 ± 9.7429.00 ± 10.5128.50 ± 2.650.845
LVEF (%)38.68 ± 15.4238.83 ± 15.0737.75 ± 19.920.923
Table 2 Comparison of echocardiographic parameters between survivors and non-survivors with cardiogenic pulmonary edema
Parameter
Survivors, median (IQR)
Non-survivors, median (IQR)
P value
E/E’11.37 (10.15-14.33)15.41 (12.70-18.17)0.291
TAPSE20.00 (17.75-26.25)19.00 (17.75-19.75)0.323
S RV12.00 (10.00-13.20)10.00 (8.25-11.75)0.339
S LV6.90 (5.97-7.62)6.75 (6.12-7.12)0.669
S LV/S RV0.60 (0.50-0.71)0.73 (0.59-0.83)0.533
LVEF37.50 (26.75-47.25)38.00 (20.75-55.00)0.844
LVOT VTI16.00 (13.38-18.25)17.00 (14.72-19.50)0.645
Table 3 Echocardiographic parameters according to ventilatory support requirements (n = 28)
Parameter
No ventilation, median (IQR)
NIV, median (IQR)
IMV, median (IQR)
P value
TAPSE19.00 (15.75-28.00)20.00 (17.50-24.00)20.50 (17.75-23.25)0.916
S RV12.35 (10.50-13.60)11.70 (9.00-12.20)11.45 (9.75-12.43)0.483
S LV6.70 (5.83-8.20)7.00 (6.00-7.75)6.75 (6.12-7.05)0.683
S LV/S RV0.62 (0.48-0.73)0.62 (0.52-0.80)0.62 (0.57-0.69)0.865
RV-RA gradient31.0 (17.75-40.25)29.0 (21.50-34.50)29.5 (26.75-35.50)0.816
E/E’12.29 (10.89-15.48)11.44 (9.97-13.92)13.61 (9.85-18.17)0.680
LVOT VTI16.40 (13.55-21.75)15.00 (13.50-18.50)15.75 (14.72-17.62)0.800
LVEF38.0 (27.25-54.00)38.0 (30.50-45.00)28.0 (20.75-40.00)0.580
Table 4 Spearman correlation analysis between echocardiographic parameters and intensive care unit length of stay
Parameter
Spearman ρ
P value
TAPSE-0.1480.444
S RV-0.0780.686
S LV-0.1890.326
S LV/S RV-0.0010.995
RV-RA gradient-0.0550.777
E-wave0.1750.363
E/E’0.1980.302
LVOT VTI0.0310.874
LVEF-0.1750.365
Table 5 Echocardiographic parameters according to inotropic support requirement
Parameter
No inotrope, median (IQR)
Inotrope, median (IQR)
P value
E/E’12.02 (10.62-14.33)13.61 (9.38-18.17)0.874
TAPSE (mm)19.50 (17.75-26.25)19.50 (17.75-20.50)0.448
S RV (cm/second)12.00 (10.00-13.20)10.00 (8.25-11.75)0.339
S LV (cm/second)6.90 (5.97-7.50)6.75 (6.12-8.00)0.973
S LV/S RV0.60 (0.50-0.71)0.73 (0.59-0.93)0.393
LVEF (%)38.50 (26.75-52.00)29.50 (20.75-42.25)0.449
LVOT VTI (cm)16.20 (13.38-19.00)14.50 (13.97-16.50)0.792


Write to the Help Desk